These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 17390046)
41. Activin receptor-like kinase 7 induces apoptosis through up-regulation of Bax and down-regulation of Xiap in normal and malignant ovarian epithelial cell lines. Xu G; Zhou H; Wang Q; Auersperg N; Peng C Mol Cancer Res; 2006 Apr; 4(4):235-46. PubMed ID: 16603637 [TBL] [Abstract][Full Text] [Related]
42. [Small interfering RNA-mediated nuclear factor-kappaB P65 suppression induces apoptosis of hepatic carcinoma SMMC-7721 cells]. Huang C; Yao JY; Li ZF; Liu LY; Ni L; Song TS Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1841-4. PubMed ID: 18158998 [TBL] [Abstract][Full Text] [Related]
43. Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines. Koike K; Takaki A; Tatsukawa M; Suzuki M; Shiraha H; Iwasaki Y; Sakaguchi K; Shiratori Y Int J Oncol; 2006 Nov; 29(5):1253-61. PubMed ID: 17016659 [TBL] [Abstract][Full Text] [Related]
44. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8. Belyanskaya LL; Ziogas A; Hopkins-Donaldson S; Kurtz S; Simon HU; Stahel R; Zangemeister-Wittke U Lung Cancer; 2008 Jun; 60(3):355-65. PubMed ID: 18093694 [TBL] [Abstract][Full Text] [Related]
46. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro. Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692 [TBL] [Abstract][Full Text] [Related]
47. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells. Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494 [TBL] [Abstract][Full Text] [Related]
48. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Lee JH; Schütte D; Wulf G; Füzesi L; Radzun HJ; Schweyer S; Engel W; Nayernia K Hum Mol Genet; 2006 Jan; 15(2):201-11. PubMed ID: 16377660 [TBL] [Abstract][Full Text] [Related]
49. Increase of Bax/ Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. Chang J; Hsu Y; Kuo P; Kuo Y; Chiang L; Lin C Life Sci; 2005 Mar; 76(16):1883-93. PubMed ID: 15698865 [TBL] [Abstract][Full Text] [Related]
50. Differential cellular expression of LIGHT and its receptors in early gestation human placentas. Gill RM; Coleman NM; Hunt JS J Reprod Immunol; 2007 Jun; 74(1-2):1-6. PubMed ID: 17010447 [TBL] [Abstract][Full Text] [Related]
51. Bcl-X(L) is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells. Dodier P; Piché A Gynecol Oncol; 2006 Feb; 100(2):254-63. PubMed ID: 16188300 [TBL] [Abstract][Full Text] [Related]
52. Study of the effects of interferon a on several human hepatoma cell lines: analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation. Legrand A; Vadrot N; Lardeux B; Bringuier AF; Guillot R; Feldmann G Liver Int; 2004 Apr; 24(2):149-60. PubMed ID: 15078480 [TBL] [Abstract][Full Text] [Related]
53. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis. Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021 [TBL] [Abstract][Full Text] [Related]
54. RNA interference by expression of short hairpin RNAs suppresses bcl-xL gene expression in nasopharyngeal carcinoma cells. Liu F; He CW; Zhang YF; Zhou KY Acta Pharmacol Sin; 2005 Feb; 26(2):228-34. PubMed ID: 15663904 [TBL] [Abstract][Full Text] [Related]
55. Expression and activation of apoptosis-related molecules involved in interferon-alpha-mediated apoptosis in human liver cancer cells. Yano H; Ogasawara S; Momosaki S; Akiba J; Nishida N; Kojiro S; Ishizaki H; Kojiro M Int J Oncol; 2005 Jun; 26(6):1645-52. PubMed ID: 15870881 [TBL] [Abstract][Full Text] [Related]
56. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells. Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933 [TBL] [Abstract][Full Text] [Related]
57. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells. Castillo J; Erroba E; Perugorría MJ; Santamaría M; Lee DC; Prieto J; Avila MA; Berasain C Cancer Res; 2006 Jun; 66(12):6129-38. PubMed ID: 16778186 [TBL] [Abstract][Full Text] [Related]
58. The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma. Nagao M; Nakajima Y; Kanehiro H; Hisanaga M; Aomatsu Y; Ko S; Tatekawa Y; Ikeda N; Kanokogi H; Urizono Y; Kobayashi T; Shibaji T; Kanamura T; Ogawa S; Nakano H Hepatology; 2000 Sep; 32(3):491-500. PubMed ID: 10960440 [TBL] [Abstract][Full Text] [Related]
59. Bcl-xL overexpression in human hepatocellular carcinoma. Watanabe J; Kushihata F; Honda K; Mominoki K; Matsuda S; Kobayashi N Int J Oncol; 2002 Sep; 21(3):515-9. PubMed ID: 12168094 [TBL] [Abstract][Full Text] [Related]
60. Attenuation of graft arterial disease by manipulation of the LIGHT pathway. Kosuge H; Suzuki J; Kakuta T; Haraguchi G; Koga N; Futamatsu H; Gotoh R; Inobe M; Isobe M; Uede T Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1409-15. PubMed ID: 15178556 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]